NOVEL IMMUNOTHERAPIES IN LYMPHOMA
With
Dr Sean Harrop
Clinical Haematology Fellow
Peter MacCallum Cancer Centre,
Melbourne, Australia
RESEARCHER PROFILE
Filmed in Melbourne, Australia | May 2025
Dr Sean Harrop is a dual-trained haematologist having completed his clinical and laboratory haematology training at the Peter MacCallum Cancer Centre, Royal Melbourne Hospital and St Vincent’s Hospital Melbourne. He is the current clinical haematology fellow (aggressive lymphoma) at Peter MacCallum and a PhD student in the Cancer Immunology Program in the Neeson Lab.
He has research interests in novel immunotherapies in lymphoma, mechanisms that lead to immunotherapy resistance and the genetic mechanisms underlying the tumour microenvironment.
He has published in peer-reviewed journals, co-authored textbook chapters and presented at international conferences on clinical and translational research in lymphoma.
Dr Harrop’s upcoming PhD is funded by the Leukaemia Foundation, Haematology Society of Australia and New Zealand (HSANZ) and the Peter MacCallum Cancer Centre.
Source: Supplied and adapted
-
Biological interactions of extracellular vesicles
Raluca Ghebosu graduated from the University of Queensland with a Bachelor of Arts/Bachelor of Science with majors in Japanese and Biomedical Science (2018-2021). She then completed her Bachelor of Science (Honours) with the School of Biomedical Sciences at the University of Queensland in 2022, before pursuing a PhD with A/Prof. Joy Wolfram at the Australian Institute for Bioengineering and Nanotechnology.
-
Clinical guidelines for diagnostics and early intervention in Primary Aldosteronism
Primary Aldosteronism (PA), or Conn Syndrome, is the most commonly under-diagnosed cause of high blood pressure affecting millions of people. Associate Professor Jun Yang’s goal is to facilitate the diagnosis of every case of PA and make treatment widely available to all communities including the disadvantaged.
-
Dr Paul Griffin
MATER HEALTH SERVICES, QUEENSLAND, AUSTRALIA
